Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest TechAtlas Group LLC Stories

2013-09-06 12:21:58

BOSTON, Sept. 6, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest Type 1 Diabetes (T1DM) competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: -- Save the cells: immune therapies for T1DM -- Beta-cell regeneration strategies -- Pancreatic replacement via...

2013-08-21 12:23:40

BOSTON, Aug. 21, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest Hepatitis C (HCV) competitive landscape map. This particular landscape highlights 25 international companies with over 60 drugs and combinations currently on the market and in development. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: -- Winning the HCV race -- Gilead: the one to beat -- Debate over what is "Good Enough" -- Other nukes --...

2013-05-17 12:23:11

BOSTON, May 17, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest update for their competitive landscape map for the Chronic Kidney Disease (CKD) market. This particular landscape highlights over 90 international companies with drugs and devices currently on the market and in development addressing CKD and its sequelae. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: hypertension - renal denervation diabetic nephropathy -...